The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 05, 2017
Filed:
Feb. 26, 2014
Applicant:
Triact Therapeutics, Inc., San Francisco, CA (US);
Inventors:
Thomas F. White, San Francisco, CA (US);
Steven Smith, San Jose, CA (US);
Assignee:
TRIACT THERAPEUTICS, INC., San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7012 (2006.01); A61K 31/7034 (2006.01); C07H 15/20 (2006.01); C07F 9/12 (2006.01); A61K 31/662 (2006.01); A61K 45/06 (2006.01); A61K 31/517 (2006.01); A61K 31/5377 (2006.01); A61K 31/661 (2006.01); C07H 15/203 (2006.01);
U.S. Cl.
CPC ...
C07H 15/20 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); A61K 31/661 (2013.01); A61K 31/662 (2013.01); A61K 31/7012 (2013.01); A61K 31/7034 (2013.01); A61K 45/06 (2013.01); C07F 9/12 (2013.01); C07H 15/203 (2013.01);
Abstract
The present application relates to compositions and methods for treating a proliferative disorder by administering to a subject a pharmaceutical composition of a dual kinase inhibitor metabolite. Catecholic butane metabolites can serve as dual kinase inhibitors for purposes of methods described herein.